12: Genetic variation may influence response to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth (PTB) prevention
Manuck T, Watkins S, Esplin M, Parry S, Zhang H, Huang H, Biggio J, Bukowski R, Saade G, Andrews W, Baldwin D, Sadovsky Y, Reddy U, Ilekis J, Varner M, Yandell M, Jorde L. 12: Genetic variation may influence response to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth (PTB) prevention. American Journal Of Obstetrics And Gynecology 2016, 214: s9-s10. DOI: 10.1016/j.ajog.2015.10.034.Peer-Reviewed Original ResearchRecurrent preterm birth preventionGenetic variationPreterm birth preventionBirth preventionHydroxyprogesterone caproate